Literature DB >> 25707625

Gynaecological cancer: New standard of care—HPV testing for cervical cancer screening.

Philip E Castle1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25707625     DOI： 10.1038/nrclinonc.2015.37

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.

Authors:  Warner K Huh; Kevin A Ault; David Chelmow; Diane D Davey; Robert A Goulart; Francisco A R Garcia; Walter K Kinney; L Stewart Massad; Edward J Mayeaux; Debbie Saslow; Mark Schiffman; Nicolas Wentzensen; Herschel W Lawson; Mark H Einstein
Journal:  Gynecol Oncol       Date:  2015-01-08       Impact factor: 5.482

2.  Increased cervical cancer risk associated with screening at longer intervals.

Authors:  Walter Kinney; Thomas C Wright; Helen E Dinkelspiel; Mark DeFrancesco; J Thomas Cox; Warner Huh
Journal:  Obstet Gynecol       Date:  2015-02       Impact factor: 7.661

3.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Authors:  Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers
Journal:  CA Cancer J Clin       Date:  2012-03-14       Impact factor: 508.702

4.  2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.

Authors:  L Stewart Massad; Mark H Einstein; Warner K Huh; Hormuzd A Katki; Walter K Kinney; Mark Schiffman; Diane Solomon; Nicolas Wentzensen; Herschel W Lawson
Journal:  J Low Genit Tract Dis       Date:  2013-04       Impact factor: 1.925

5.  Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.

Authors:  Thomas C Wright; Mark H Stoler; Catherine M Behrens; Abha Sharma; Guili Zhang; Teresa L Wright
Journal:  Gynecol Oncol       Date:  2015-01-08       Impact factor: 5.482

6.  Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000.

Authors:  Sophia S Wang; Mark E Sherman; Allan Hildesheim; James V Lacey; Susan Devesa
Journal:  Cancer       Date:  2004-03-01       Impact factor: 6.860

7.  Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial.

Authors:  Christine Bergeron; Paolo Giorgi-Rossi; Frederic Cas; Maria Luisa Schiboni; Bruno Ghiringhello; Paolo Dalla Palma; Daria Minucci; Stefano Rosso; Manuel Zorzi; Carlo Naldoni; Nereo Segnan; Massimo Confortini; Guglielmo Ronco
Journal:  J Natl Cancer Inst       Date:  2015-01-07       Impact factor: 13.506

8.  Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study.

Authors:  Joakim Dillner; Matejka Rebolj; Philippe Birembaut; Karl-Ulrich Petry; Anne Szarewski; Christian Munk; Silvia de Sanjose; Pontus Naucler; Belen Lloveras; Susanne Kjaer; Jack Cuzick; Marjolein van Ballegooijen; Christine Clavel; Thomas Iftner
Journal:  BMJ       Date:  2008-10-13

9.  50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence.

Authors:  S Vaccarella; S Franceschi; G Engholm; S Lönnberg; S Khan; F Bray
Journal:  Br J Cancer       Date:  2014-07-03       Impact factor: 7.640

10.  Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.

Authors:  Guglielmo Ronco; Joakim Dillner; K Miriam Elfström; Sara Tunesi; Peter J F Snijders; Marc Arbyn; Henry Kitchener; Nereo Segnan; Clare Gilham; Paolo Giorgi-Rossi; Johannes Berkhof; Julian Peto; Chris J L M Meijer
Journal:  Lancet       Date:  2013-11-03       Impact factor: 79.321
  10 in total
  3 in total

1.  Implementation considerations using HPV self-collection to reach women under-screened for cervical cancer in high-income settings.

Authors:  H N Pedersen; L W Smith; C Sarai Racey; D Cook; M Krajden; D van Niekerk; G S Ogilvie
Journal:  Curr Oncol       Date:  2018-02-28       Impact factor: 3.677

2.  HPV E6/p53 mediated down-regulation of miR-34a inhibits Warburg effect through targeting LDHA in cervical cancer.

Authors:  Rong Zhang; Jing Su; Song-Lin Xue; Hui Yang; Li-Li Ju; Ying Ji; Kai-Hua Wu; Yan-Wei Zhang; Ye-Xin Zhang; Jian-Fang Hu; Min-Min Yu
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

3.  Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex.

Authors:  Yayun Jiang; Wei Ren; Weijia Wang; Jing Xia; Liyao Gou; Mengyao Liu; Qun Wan; Lan Zhou; Yaguang Weng; Tongchuan He; Yan Zhang
Journal:  Oncol Rep       Date:  2017-09-18       Impact factor: 3.906
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.